Femtomolar-level PCR-free quantification of microRNA cancer biomarkers in serum
Kanavarioti, A.
Show abstract
We developed a technology to measure microRNA (miRNA) copies in serum and tested it on a commercially available combined human serum (H6914 from Sigma-Aldrich). Copies of miR-15b and miR-16, believed to be constant among healthy and diseased individuals, were measured and agreed with the ones reported by Mitchell PS et al. (2008). Cancer biomarkers let7-b, miR-21, miR-141 and miR-375 varied 3,000 to 6,000 copies per 1 microLiter H6914 (5-10 femtomolar (fM)). Detection and quantification of oligos and miRNAs at such low concentration was shown earlier. It is accomplished by repurposing the commercial MinION nanopore platform to conduct single-molecule voltage-driven ion-channel measurements, employing osmium-tagged oligo probes, and using a publicly available algorithm. These miRNAs were quantified in the serum of healthy individuals or cancer patients using novel optimized probes and a detailed protocol that delivers miRNA copies with better than 85% confidence across all concentrations. A linear correlation, the same with healthy and cancer serum samples, is observed between miR-15b copies and RNA concentration in serum. The assays simplicity, readiness, sensitivity, and precision advocate for its use as a Laboratory Developed Test (LDT) for disease-screening based on miRNA dysregulation.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Hairpin structure facilitates high-fidelity DNA amplification reactions in both qPCR and high-throughput sequencing 94%
- Nucleic acid quantification with amplicon yield in recombinase polymerase amplification 94%
- homeRNA: A self-sampling kit for the collection of peripheral blood and stabilization of RNA 94%
Similar papers in this journal
- Ready-to-use nanopore platform for the detection of any DNA/RNA oligo at attomole range using an Osmium tagged complementary probe. 98%
- Nanopore device-based fingerprinting of RNA oligos and microRNAs enhanced with an Osmium tag. 97%
- Evaluating and mitigating clinical samples matrix effects on TX-TL cell-free performance 94%
Similar papers in this journal
- Hitting the diagnostic sweet spot: Point-of-care SARS-CoV-2 salivary antigen testing with an off-the-shelf glucometer 94%
- Point-of-Care CRISPR-Cas-Assisted SARS-CoV-2 Detection in an Automated and Mobile Droplet Magnetofluidic Device 93%
- Sensitive quantitative detection of SARS-CoV-2 in clinical samples using digital warm-start CRISPR assay 93%
Similar papers in this journal
- RNA cytometry of single-cells using semi-permeable microcapsules 95%
- Unlocking the Full Potential of Nanopore Sequencing: Tips, Tricks, and Advanced Data Analysis Techniques 95%
- Direct RNA sequencing (RNA004) allows for improved transcriptome assessment and near real-time tracking of methylation for medical applications 95%
Similar papers in this journal
- Point-of-care detection of SARS-CoV-2 in nasopharyngeal swab samples using an integrated smartphone-based centrifugal microfluidic platform 94%
- Quantitative Isothermal Amplification on Paper Membranes using Amplification Nucleation Site Analysis 94%
- SNAPflex: a paper-and-plastic device for instrument-free RNA and DNA extraction from whole blood 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.